Funding, News and Announcements

Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments.

Now in its 5^th year, the Canada: Rapid Response 2017 program provides seed funding for high-risk, high-reward, translational research projects on neurodegenerative diseases of aging.

NEW for 2017:

1. The Canada: Rapid Response program will run multiple application calls per year, alternating  between two different disease groups (outlined below). Applicants should apply to the group best suited to their project.
2. Projects may request up to $200,000 per project over up to 18 months, as determined by the Institute
3. Applicants may appear in any role on any number of Letters of Intent (LOI).

Program Overview

Please refer to the Program Details and Request for Applications (RFA) document for more information.

Goal: To provide funding for novel, high-risk, high-reward, translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.

Funding: A maximum of $200,000 over up to 18 months per project.

Applicant Eligibility: Eligible Principal Applicants must be researchers working in Canada at least 30% of the time at or above the level of Postdoctoral Fellow, and affiliated with a Canada Revenue Agency-qualified donee institution located in Canada.

If the Principal Applicant is not appointed at the institution from which they are applying, they need to apply with a research supervisor (an “Administrative Supervisor”) at or above the level of Assistant Professor or equivalent, with an appointment at the institution from which they are applying.

Applicants may appear in any role on any number of LOIs.

Project Eligibility: Projects must meet two conditions to be eligible,

1. Be translational research that helps accelerate the development of therapeutics for neurodegenerative diseases of aging
2. Be the development of a therapeutic and/or tool

Please refer to Funding Overview  for Institute definitions of neurodegenerative diseases of aging, translational research, therapeutic, and tool.

For further details, please refer to the Request for Applications (pdf) or visit the the Weston Brain Institute website here.

Webinar

The Institute will hold a Program Information Webinar to provide further details on the program and answer any questions.

Information Webinar (PD-related)   April 4, 2017 at 1:00pm EDT. Register here.

Information Webinar (AD-related)   June 12, 2017 at 1:00pm EDT. Register here.

The Institute welcomes inquiries about this program or any of our other funding opportunities. Contact us at neuro@weston.ca or +1 416-935-4056.